Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03485040 · ClinicalTrials.gov registry record
Stroke Motor Rehabilitation and Recovery Study
A clinical trial of Stroke, Ischemic, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT03485040 is a study of Stroke, Ischemic that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 300 participants, roughly in line with the 281-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT03485040, a study of Stroke, Ischemic, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-06-09 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03485040
The ClinicalTrials.gov registry entry for NCT03485040 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 281-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stroke, Ischemic appearing as the primary indexed condition, and to 0 interventions.
NCT03485040 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03485040 about?
NCT03485040 is a clinical study titled "Stroke Motor Rehabilitation and Recovery Study". SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.
What is the current status of trial NCT03485040?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2017-06-09. Estimated completion is 2027-06-30.
What conditions does trial NCT03485040 study?
This clinical trial studies the following conditions: Stroke, Ischemic.
Who is sponsoring clinical trial NCT03485040?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03485040 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
RECRUITING
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
RECRUITING
-
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
RECRUITING · Phase 1
-
Promoting Recovery After STroke With Amantadine
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.